STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19

NCT04817332 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

406

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Brensocatib
DRUG: Placebo

Sponsor

University of Dundee

Collaborators

[object Object]
[object Object]